Trials / Unknown
UnknownNCT04929873
Clinical Study of VA-ECMO Remote Limb Re-perfusion Monitoring Technology
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 72 (estimated)
- Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Establish and verify the feasibility and effectiveness of VA-ECMO remote limb re-perfusion monitoring technology.
Detailed description
It is proposed to monitor VA-ECMO arterial end side branch circulation in real time through a set of monitoring equipment, guide clinical adjustment, improve lower limb re-perfusion, reduce the occurrence of lower limb ischemia, in order to achieve the goal of early detection, early prevention and early treatment, and provide reference and theoretical basis for clinical practice. Monitoring techniques are divided into two parts: A. monitoring equipment (connecting transdiotic monitoring pressure on va-ECMO side branches cycle); B.to guide clinical adjustment by monitoring pressure (average arterial pressure).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Closed transdyser | When the average arterial pressure ≥ 50mmHg, it is indicated that the basic blood supply of the lower extremities is satisfied without special treatment, and when the average arterial pressure \< 50mmHg, it indicates insufficient perfusion, by adjusting the pipe position, changing the ECMO flow rate, and properly clamping the artery end to divert part of the blood flow to the side branch circulation, so that the average arterial pressure is maintained above 50mmHg. |
| BEHAVIORAL | Routine monitor | Obtain oxygen saturation, skin color, temperature, etc |
Timeline
- Start date
- 2020-01-01
- Primary completion
- 2021-10-30
- Completion
- 2022-12-31
- First posted
- 2021-06-18
- Last updated
- 2021-06-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04929873. Inclusion in this directory is not an endorsement.